Sana Biotechnology (SANA) Other Non Operating Income (2020 - 2026)
Sana Biotechnology (SANA) posted Other Non Operating Income of $453000.0 for Q1 2026, down 58.74% sequentially from $1.1 million in Q4 2025, and up 81.93% YoY from $249000.0 in Q1 2025.
Powered by 
Analysis
Sana Biotechnology (SANA) Other Non Operating Income (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Other Non Operating Income for 7 years, with the latest figure at $453000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 81.93% year-over-year to $453000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 156.09% YoY) and the FY2025 annual result came in at $2.3 million, up 151.14% from the prior year.
- Other Non Operating Income slipped to $453000.0 in Q1 2026 per SANA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.1 million in Q4 2025 and troughed at -$4.1 million in Q2 2024.
- A 5-year average of -$145588.2 and a median of -$47000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 19900.0% in 2022, then surged 678.72% in 2025.
- Over 5 years, Other Non Operating Income stood at -$268000.0 in 2022, then rose by 16.42% to -$224000.0 in 2023, then jumped by 162.95% to $141000.0 in 2024, then soared by 678.72% to $1.1 million in 2025, then tumbled by 58.74% to $453000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $453000.0, $1.1 million, and $360000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sana Biotechnology | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 598,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | -742,000.00 |
| Jun 30, 2024 | -4.12 Mn |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | -224,000.00 |
| Sep 30, 2023 | 303,000.00 |
| Jun 30, 2023 | -84,000.00 |
| Mar 31, 2023 | -47,000.00 |
| Dec 31, 2022 | -268,000.00 |
| Sep 30, 2022 | -106,000.00 |
| Jun 30, 2022 | -198,000.00 |
| Mar 31, 2022 | -102,000.00 |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 10,000.00 |